Neumología
Especialidad
Imperial College London
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Imperial College London (26)
2024
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Impact of long-term exposure to ambient ozone on lung function over a course of 20 years (The ECRHS study): a prospective cohort study in adults
The Lancet Regional Health - Europe, Vol. 34
-
Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS
Thorax, Vol. 78, Núm. 2, pp. 128-135
-
Residential greenspace and lung function decline over 20 years in a prospective cohort: The ECRHS study
Environment International, Vol. 178
2022
-
An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study
Metabolites, Vol. 12, Núm. 12
-
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231
2021
-
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
ERJ Open Research, Vol. 7, Núm. 4
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
Journal of global health, Vol. 11, pp. 15003
-
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
The Lancet Respiratory Medicine, Vol. 9, Núm. 12, pp. 1467-1478
2020
-
Are symptoms of insomnia related to respiratory symptoms? Cross-sectional results from 10 European countries and Australia
BMJ Open, Vol. 10, Núm. 4
-
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 5, pp. 453-460
2019
-
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
The Lancet Respiratory Medicine, Vol. 7, Núm. 9, pp. 771-779
-
Effects of smoking bans on passive smoking exposure at work and at home. The European Community respiratory health survey
Indoor Air, Vol. 29, Núm. 4, pp. 670-679
-
Restrictive spirometry pattern is associated with low physical activity levels. A population based international study
Respiratory Medicine, Vol. 146, pp. 116-123
-
Second-hand smoke exposure in adulthood and lower respiratory health during
Respiratory Research, Vol. 20, Núm. 1
-
Time and age trends in smoking cessation in Europe
PLoS ONE, Vol. 14, Núm. 2
2018
-
A three-generation study on the association of tobacco smoking with asthma
International Journal of Epidemiology, Vol. 47, Núm. 4, pp. 1106-1117